Katrina Wilcox Hagberg – Page 2 – Boston Collaborative Drug Surveillance Program (BCDSP)

CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities

By BCDSP September 28, 2020Recent work examples, Select Publications, Validation Studies

Journal: Pharmacoepidemiology and Drug Safety Authors: Rebecca Persson, Catherine Vasilakis-Scaramozza, Katrina Wilcox Hagberg, Todd Sponholtz, Tim Williams, Puja Myles, Susan S Jick NML Citation: Persson R, Vasilakis-Scaramozza C, Hagberg KW, Sponholtz T, Williams T, Myles P,…

Quality and completeness of diagnoses recorded in the new CPRD Aurum database: evaluation of pulmonary embolism

By BCDSP March 28, 2020Recent work examples, Select Publications, Validation Studies

Journal: Pharmacoepidemiology and Drug Safety Authors: Susan S Jick, Katrina Wilcox Hagberg, Rebecca Persson, Catherine Vasilakis-Scaramozza, Tim Williams, Elizabeth Crellin, Puja Myles NLM Citation: Jick SS, Hagberg KW, Persson R, Vasilakis-Scaramozza C, Williams T, Crellin E,…

The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database

By BCDSP March 25, 2020Drug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications

Journal: Journal of the American Academy of Dermatology Authors: Rebecca Persson, Katrina Wilcox Hagberg, Yiran Qian, Catherine Vasilakis-Scaramozza, Susan Jick NLM Citation: Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risk…

The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database

By BCDSP February 28, 2020Drug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications

Journal: Journal of the European Academy of Dermatology and Venereology Authors: C Vasilakis-Scaramozza, R Persson, K W Hagberg, S Jick NLM Citation: Vasilakis-Scaramozza C, Persson R, Hagberg KW, Jick S. The risk of…

Herpes zoster, hepatitis C, and tuberculosis risk with apremilast compared to biologics, DMARDs and corticosteroids to treat psoriasis and psoriatic arthritis

By BCDSP February 12, 2020Drug Safety Studies, Safety of new therapies for autoimmune disorders, Select Publications

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Rebecca Persson, Catherine Vasilakis-Scaramozza, Steve Niemcryk, Michael Peng, Maria Paris, Anders Lindholm, Susan Jick NLM Citation: Hagberg KW, Persson R, Vasilakis-Scaramozza C, Niemcryk S, Peng M, Paris M, Lindholm A,…

Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring

By BCDSP November 1, 2018Developmental Disabilities, Drug Safety Studies, Mental Health, Other important conditions, Safety of drugs in pregnancy, Select Publications

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Annelies L Robijn, Susan Jick NLM Citation: Hagberg KW, Robijn AL, Jick S. Maternal depression and antidepressant use during pregnancy and the risk of autism…

Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014

By BCDSP September 15, 2017CPRD, Developmental Disabilities, Outcome and Exposure validation, Select Publications, Validation Studies

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Susan S Jick NLM Citation: Hagberg KW, Jick SS. Validation of autism spectrum disorder diagnoses recorded in the Clinical Practice Research Datalink, 1990-2014. Clin…

Risk of Incident Antidepressant-Treated Depression Associated with Use of 5α-Reductase Inhibitors Compared with Use of α-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink

By BCDSP May 2, 2017Uncategorized

Journal: Pharmacotherapy Authors: Katrina Wilcox Hagberg 1, Hozefa A Divan 2, J Curtis Nickel 3, Susan S Jick 1 NLM Citation: Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use…

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

By BCDSP February 10, 2017Drug Safety Studies, Safety of other important drugs, Select Publications

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Shona C Fang, J Curtis Nickel, Susan S Jick 1 NLM Citation: Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia…

Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

By BCDSP September 22, 2016Drug Safety Studies, Safety of other important drugs, Select Publications

Journal: BMJ (Clinical research ed.) Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Rebecca Persson, J Curtis Nickel, Susan S Jick NLM Citation: Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. Risk of…